Orexo (OX-MPI Project) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Orexo (OX-MPI Project) General Information
Description
A pharmaceutical project in Uppsala, Sweden. The project deals with highly selective anti-inflammatory compound targeting microsomal prostaglandin E synthase (mPGES-1).
Contact Information
Corporate Office
- P.O. Box 303
- 751 05 Uppsala
- Sweden
Corporate Office
- P.O. Box 303
- 751 05 Uppsala
- Sweden
Orexo (OX-MPI Project) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Orexo (OX-MPI Project) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Orexo (OX-MPI Project) FAQs
-
Where is Orexo (OX-MPI Project) headquartered?
Orexo (OX-MPI Project) is headquartered in Uppsala, Sweden.
-
What industry is Orexo (OX-MPI Project) in?
Orexo (OX-MPI Project)’s primary industry is Buildings and Property.
-
Is Orexo (OX-MPI Project) a private or public company?
Orexo (OX-MPI Project) is a Private company.
-
What is Orexo (OX-MPI Project)’s current revenue?
The current revenue for Orexo (OX-MPI Project) is .
-
Who are Orexo (OX-MPI Project)’s investors?
Orexo has invested in Orexo (OX-MPI Project).
-
When was Orexo (OX-MPI Project) acquired?
Orexo (OX-MPI Project) was acquired on 29-Sep-2017.
-
Who acquired Orexo (OX-MPI Project)?
Orexo (OX-MPI Project) was acquired by Gesynta Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process